- Home
- XPL vs ECOR Comparison
XPL vs ECOR Comparison
Compare XPL & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPL
- ECOR
- Stock Information
- Founded
- XPL 1984
- ECOR 2005
- Country
- XPL United States
- ECOR United States
- Employees
- XPL N/A
- ECOR N/A
- Industry
- XPL Precious Metals
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- XPL Basic Materials
- ECOR Health Care
- Exchange
- XPL Nasdaq
- ECOR Nasdaq
- Market Cap
- XPL 46.5M
- ECOR 40.1M
- IPO Year
- XPL N/A
- ECOR 2018
- Fundamental
- Price
- XPL $0.61
- ECOR $6.59
- Analyst Decision
- XPL Strong Buy
- ECOR Strong Buy
- Analyst Count
- XPL 2
- ECOR 2
- Target Price
- XPL $1.60
- ECOR $25.50
- AVG Volume (30 Days)
- XPL 62.5K
- ECOR 125.1K
- Earning Date
- XPL 05-05-2025
- ECOR 05-07-2025
- Dividend Yield
- XPL N/A
- ECOR N/A
- EPS Growth
- XPL N/A
- ECOR N/A
- EPS
- XPL N/A
- ECOR N/A
- Revenue
- XPL N/A
- ECOR $25,182,000.00
- Revenue This Year
- XPL N/A
- ECOR $32.20
- Revenue Next Year
- XPL N/A
- ECOR $46.27
- P/E Ratio
- XPL N/A
- ECOR N/A
- Revenue Growth
- XPL N/A
- ECOR 57.09
- 52 Week Low
- XPL $0.54
- ECOR $5.02
- 52 Week High
- XPL $0.98
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- XPL 52.41
- ECOR 40.33
- Support Level
- XPL $0.63
- ECOR $5.20
- Resistance Level
- XPL $0.68
- ECOR $7.07
- Average True Range (ATR)
- XPL 0.04
- ECOR 0.72
- MACD
- XPL 0.01
- ECOR 0.41
- Stochastic Oscillator
- XPL 63.93
- ECOR 76.59
About XPL Solitario Resources Corp.
Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.